Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arterial Remodeling Technologies ("ART")
Bioresorbable Stent Company, Arterial Remodeling Technologies (''ART''), Appoints Machiel Van Der Leest as Chief Operating Officer
April 11th, 2008
Arterial Remodeling Technologies ("ART") announced that it has appointed Machiel Van Der Leest as its Chief Operating Officer, effective April 2008. Most recently, Van Der Leest was Director of R&D and Regulatory Affairs since May 2003 at Minvasys, which is focused on bifurcation treatment with dedicated devices. ART recently leased a manufacturing facility (20,000 square feet) as a result of mastering proprietary polymer-based manufacturing technology to produce bioresorbable stents. The company's bioresorbable stents, which can be manufactured at very low cost, are designed to dismantle in vivo over an optimized time horizon, thus allowing the body's natural arterial...
Source: Health Business Week (2008-04-11)
|
